Anavex Life Sciences NEWS
Anavex Life Sciences (AVXL) reported a new peer reviewed publication in journal Neurobiology of Aging, titled “Early treatment with an M1 and sigma 1 receptor agonist . . .
This content is for paid subscribers.
Impacting News
October 26, 2023
